J&J suspends COVID-19 vaccine sales forecast - The Associated Press
4/19/2022 12:00:00 AM3 yearsago
by Tom Murphy
by Tom Murphy
Johnson & Johnson is suspending sales forecasts for its COVID-19 vaccine only a few months after saying the shot could bring in as much as $3.5 billion this year. A global supply surplus and uncertainty about future demand — fueled in part by vaccine hesitanc…
Johnson & Johnson is suspending sales forecasts for its COVID-19 vaccine only a few months after saying the shot could bring in as much as $3.5 billion this year. A global supply surplus and unc… [+2696 chars]
full article...